LivaNova Plc (LIVN)
63.59
+0.53
(+0.84%)
USD |
NASDAQ |
Dec 16, 09:33
LivaNova Cash from Investing (Quarterly): -23.06M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| NovoCure Ltd. | 71.44M |
| Abbott Laboratories | -457.00M |
| ResMed, Inc. | -52.58M |
| Perspective Therapeutics, Inc. | 13.99M |
| Xtant Medical Holdings, Inc. | 4.679M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 85.06M |
| Cash from Financing (Quarterly) | -9.373M |
| Free Cash Flow | 191.43M |
| Free Cash Flow Per Share (Quarterly) | 1.127 |
| Free Cash Flow to Equity (Quarterly) | 58.41M |
| Free Cash Flow to Firm (Quarterly) | 70.76M |
| Free Cash Flow Yield | 5.50% |